Pacific Biosciences of California Inc

11.11.2026 г., 23:01 ч. UTC

Pacific Biosciences of California, Inc. is trading higher in after-market hours, maintaining a cumulative return since Wednesday's close amid a broader market rise.

10.11.2026 г., 22:01 ч. UTC

Pacific Biosciences announces a sales agreement with Allen & Co. for up to $100 million in common stock through an at-the-market equity offering program.

9.11.2026 г., 21:03 ч. UTC

Pacific Biosciences is advancing sharply, reaching its highest cumulative return since Friday, despite initial volatility earlier in the session.

7.11.2026 г., 00:01 ч. UTC

Pacific Biosciences of California, Inc. shares are trading modestly lower in after-market hours, continuing a trend of lower closes over the past three sessions.

6.11.2026 г., 23:41 ч. UTC

Pacific Biosciences of California, Inc. is trading modestly lower in after-market hours, marking its fourth consecutive session of declines.

5.11.2026 г., 23:36 ч. UTC

ARK Genomic Revolution ETF declined in after-market trading as several holdings reported larger-than-expected net losses, with Pacific Biosciences also falling modestly.

4.11.2026 г., 23:31 ч. UTC

Pacific Biosciences reports Q3 revenue of $40.6 million, exceeding expectations, and narrows 2026 revenue guidance to $155 million to $160 million.

3.11.2026 г., 23:41 ч. UTC

Pacific Biosciences is advancing in after-market trading, supported by positive economic indicators and a broadly higher market, despite mixed earnings from Apple.

2.11.2026 г., 23:11 ч. UTC

Pacific Biosciences of California, Inc. is seeing notable strength in after-market trading, recovering from a low point shortly after the market closed.

31.10.2026 г., 00:01 ч. UTC

In after-market trading, Pacific Biosciences of California, Inc. has advanced sharply since Friday's close, remaining well above its 20-day moving average.

30.10.2026 г., 23:41 ч. UTC

Pacific Biosciences is advancing in after-market trading, reaching a high that significantly exceeds Friday's close and is well above its 20-day moving average.

29.10.2026 г., 23:01 ч. UTC

Pacific Biosciences of California, Inc. is trading lower in after-market hours, reflecting a broader market decline influenced by disappointing earnings from Illumina.

28.10.2026 г., 23:02 ч. UTC

Pacific Biosciences of California, Inc. is trading lower in after-market hours, reflecting the broader market's decline following the Fed's interest rate decision.

27.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California, Inc. is trading modestly lower in after-market hours, continuing a downward trend despite strong performance over the past month.

26.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, retracing from an earlier gain, despite a strong one-month performance.

23.10.2026 г., 19:16 ч. UTC

Pacific Biosciences of California Inc is trading roughly flat, showing little change since Thursday's close, while remaining below its 20-day moving average.

22.10.2026 г., 19:56 ч. UTC

Pacific Biosciences of California Inc shares fell, influenced by declines in the ARK Genomic Revolution ETF and its holdings, including 10X Genomics and Illumina.

21.10.2026 г., 23:16 ч. UTC

Pacific Biosciences of California Inc is trading modestly higher in after-market hours, marking its fifth consecutive session of gains.

20.10.2026 г., 23:16 ч. UTC

Pacific Biosciences of California Inc is trading modestly higher in after-market hours following Tuesday's close, amid ongoing volatility within its one-month trading range.

19.10.2026 г., 20:07 ч. UTC

Pacific Biosciences announces a multi-year collaboration with Verily Health to integrate HiFi sequencing technology with Verily's AI platform for clinico-genomic datasets.

16.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California Inc is effectively unchanged in after-market trading, having retraced from earlier highs amid recent declines below its 20-day moving average.

15.10.2026 г., 23:02 ч. UTC

After-market hours, the ARK Genomic Revolution ETF (ARKG) is trading higher, supported by a Neutral rating for CRISPR Therapeutics from UBS and gains in key holdings.

14.10.2026 г., 23:21 ч. UTC

Pacific Biosciences shares declined in after-market trading, marking the fourth consecutive session of lower prices, reaching a recent low shortly before the latest timestamp.

13.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California Inc's shares were roughly flat in after-market trading, following three consecutive lower daily closes while remaining above the 20-day moving average.

12.10.2026 г., 22:16 ч. UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, with the stock positioned around the middle of its one-month range.

9.10.2026 г., 20:07 ч. UTC

UBS initiated coverage of Pacific Biosciences with a Neutral rating and a price target of $1.35, adjusting its Fair Value estimate to $2.40 per share.

8.10.2026 г., 23:20 ч. UTC

Pacific Biosciences shares declined significantly in after-market trading, reversing earlier gains and marking a notable drop compared to Thursday's close.

7.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California Inc declined during after-market hours on Wednesday, retracing significantly from its prior close despite strong recent performance.

6.10.2026 г., 23:06 ч. UTC

Pacific Biosciences of California Inc declined in after-market trading, moving lower since Tuesday's close, despite strong performance over the past month.

5.10.2026 г., 20:03 ч. UTC

Pacific Biosciences of California Inc is higher in Monday's trading, continuing its upward trend since Friday, despite earlier pulling back from a session high.